The company, co-founded by Nobel Laureate Craig Mello, aims to push molecules for Huntington’s and a form of epilepsy into ...

Huntington’s disease arises from a genetic mutation ... Unlike the fibrils associated with Alzheimer’s or Parkinson’s diseases, those formed by polyQ proteins present unique structural ...

Neurizon Therapeutics has achieved a key milestone with a patent granted in the US for its lead drug candidate NUZ-001 to ...

Mitochondria are crucial organelles for cellular homeostasis, regulating processes such as ATP production, reactive oxygen species (ROS) management and Ca2+ signaling.

Financial writer recommends Voyager Therapeutics, Inc. for high-risk investors due to promising preclinical Alzheimer's ...

Mitochondria are critical for cellular homeostasis, regulating bioenergetics, redox balance, Ca2+ signaling, and cell death.

South San Francisco, CA, January 30, 2025 – The California Institute for Regenerative Medicine (CIRM), one of the world’s largest institutions dedicated to regenerative medicine, has awarded nearly ...

Its potential in Huntington's disease emerged thanks to an AI drug ... Xenazine is associated with severe side effects including sedation, parkinsonism and the risk of depression and suicidality ...

A deficiency in calcium can lead to osteoporosis, a condition that weakens bones and increases fracture risk. Calcium is also ...

Since then, Biogen decided to opt out of their partnership on essential tremor candidate SAGE-324 after disappointing results ...

Inside the $32 billion industry transforming marijuana, its consumption and beliefs about its ability to heal.